| Molecular and clinical significance of fibroblast growth factor 2 (FGF2/bFGF) in malignancies of solid and hematological cancers for personalized therapies MR Akl, P Nagpal, NM Ayoub, B Tai, SA Prabhu, CM Capac, M Gliksman, ... Oncotarget 7 (28), 44735, 2016 | 190 | 2016 |
| Molecular and clinical profiles of syndecan-1 in solid and hematological cancer for prognosis and precision medicine MR Akl, P Nagpal, NM Ayoub, SA Prabhu, M Gliksman, B Tai, A Hatipoglu, ... Oncotarget 6 (30), 28693, 2015 | 88 | 2015 |
| Prevalence of Chlamydia infection among women visiting a gynaecology outpatient department: evaluation of an in-house PCR assay for detection of Chlamydia trachomatis AL Patel, D Sachdev, P Nagpal, U Chaudhry, SC Sonkar, SL Mendiratta, ... Annals of Clinical Microbiology and Antimicrobials 9, 1-10, 2010 | 81 | 2010 |
| An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae AL Patel, U Chaudhry, D Sachdev, PN Sachdeva, M Bala, D Saluja Indian Journal of Medical Research 134 (4), 419-431, 2011 | 48 | 2011 |
| Pediatric Hodgkin lymphoma–biomarkers, drugs, and clinical trials for translational science and medicine P Nagpal, MR Akl, NM Ayoub, T Tomiyama, T Cousins, B Tai, N Carroll, ... Oncotarget 7 (41), 67551, 2016 | 47 | 2016 |
| Comparison of an in-house PCR assay, direct fluorescence assay and the Roche AMPLICOR Chlamydia trachomatis kit for detection of C. trachomatis PS Daman Saluja, Achchhe L Patel, Divya Sachdev, Aruna Mittal Journal of medical microbiology 58, 867-73, 2009 | 39 | 2009 |
| The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes P Nagpal, DB Descalzi‐Montoya, N Lodhi Cancer Reports 4 (2), e1311, 2021 | 20 | 2021 |
| Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine N Lodhi, M Tun, P Nagpal, AA Inamdar, NM Ayoub, N Siyam, ... Oncotarget 11 (44), 4045, 2020 | 14 | 2020 |
| Molecular and clinical significance of fibroblast growth factor 2 (FGF2/bFGF) in malignancies of solid and hematological cancers for personalized therapies. Oncotarget. 2016; 7 … MR Akl, P Nagpal, NM Ayoub, B Tai, SA Prabhu, CM Capac, M Gliksman, ... Epub 2016/03/24. doi: 10.18632/oncotarget. 8203. PubMed PMID: 27007053, 0 | 9 | |
| Molecular and clinical significance of fibroblast growth factor 2 (FGF2/bFGF) in malignancies of solid and hematological cancers for personalized therapies. Oncotarget. 7 … MR Akl, P Nagpal, NM Ayoub, B Tai, SA Prabhu, CM Capac, M Gliksman, ... | 5 | 2016 |
| A novel cell-penetrating peptide to facilitate intercellular transport of fused proteins Y Shen, P Nagpal, JG Hay, H Sauthoff Journal of controlled release 188, 44-52, 2014 | 5 | 2014 |
| High Expression of FGF2/SDC1 Signaling Contributes to Poor Clinical Outcome in Hodgkin Lymphoma Patients and SDC1 siRNA Suppresses Proliferation, Migration, and Invasion in … P Nagpal, A Goy, A Gangadharan, MR Akl, I Voznenko, M Soni, B Tai, ... Blood 130, 1483, 2017 | 1 | 2017 |
| Synergetic effect of high dose rate radiations (10× FFF/2400 MU/min/10 MV x‐rays) and paclitaxel selectively eliminates melanoma cells N Lodhi, P Nagpal, S Sarojini, M Keck, YM Chiu, Z Parvez, L Adrianzen, ... Cancer Reports 6 (2), e1733, 2023 | | 2023 |
| Combination of High Dose Rate Radiations (10X FFF/2400 MU/min/10 MV X-rays) and Paclitaxel Selectively Eliminates Melanoma Cells N Lodhi, S Sarojini, M Keck, P Nagpal, YM Chiu, Z Parvez, L Adrianzen, ... bioRxiv, 2021.07. 22.453100, 2021 | | 2021 |
| A Novel Protein Transduction Domain with Improved Secretion and Transduction Activity Open Archive HS Ying Shen, William Yu, Poonam Nagpal, John G. Hay Molecular Therapy 19 (Supplement 1), pS160, 2011 | | 2011 |
| Identification of novel mutations in mtr locus of clinical isolates of Neisseria gonorrhoeae: O128 M Ali, V Kumar, P Sachdeva, U Chaudhry, D Saluja Clinical Microbiology & Infection 12, 2006 | | 2006 |
